Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
55.45
-2.11 (-3.67%)
At close: Apr 9, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.